Mitophagy in Doxorubicin-Induced Cardiotoxicity: Insights into Molecular Biology and Novel Therapeutic Strategies
Biomolecules · 17.12.2024 · 14 (12) · 1614
DOI: 10.3390/biom14121614 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 17.12.2024. Verfasst von Heng Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Hauptthemen laut MEDLINE: Mitophagy, Doxorubicin, Cardiotoxicity. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Research & Development plan of Hubei Province, Regional Innovation and Development Joint Fund of National Natural Science Foundation of China.
Abstract (Originalsprache)
Doxorubicin is a chemotherapeutic drug utilized for solid tumors and hematologic malignancies, but its clinical application is hampered by life-threatening cardiotoxicity, including cardiac dilation and heart failure. Mitophagy, a cargo-specific form of autophagy, is specifically used to eliminate damaged mitochondria in autophagosomes through hydrolytic degradation following fusion with lysosomes. Recent advances have unveiled a major role for defective mitophagy in the etiology of DOX-induced cardiotoxicity. Moreover, specific interventions targeting this mechanism to preserve mitochondrial function have emerged as potential therapeutic strategies to attenuate DOX-induced cardiotoxicity. However, clinical translation is challenging because of the unclear mechanisms of action and the potential for pharmacological adverse effects. This review aims to offer fresh perspectives on the role of mitophagy in the development of DOX-induced cardiotoxicity and investigate potential therapeutic strategies that focus on this mechanism to improve clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Hubei Key Laboratory of Metabolism and Related Chronic Diseases, Wuhan 430060, China.
ORCID-Profile: Heng Zhang, Saiyang Xie, Wei Deng
Förderung
- National Natural Science Foundation of China
- Research & Development plan of Hubei Province
- Regional Innovation and Development Joint Fund of National Natural Science Foundation of China
- Research and Development plan of Hubei Province
Zitieren
APA
Zhang, H., Xie, S., & Deng, W. (2024). Mitophagy in Doxorubicin-Induced Cardiotoxicity: Insights into Molecular Biology and Novel Therapeutic Strategies. Biomolecules, 14(12), 1614. https://doi.org/10.3390/biom14121614
Vancouver
Zhang H, Xie S, Deng W. Mitophagy in Doxorubicin-Induced Cardiotoxicity: Insights into Molecular Biology and Novel Therapeutic Strategies. Biomolecules. 2024;14(12):1614. doi:10.3390/biom14121614
BibTeX
@article{Zhang2024,
author = {Zhang, Heng and Xie, Saiyang and Deng, Wei},
title = {Mitophagy in Doxorubicin-Induced Cardiotoxicity: Insights into Molecular Biology and Novel Therapeutic Strategies},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {12},
pages = {1614},
doi = {10.3390/biom14121614}
}
EUVIMED